Immunovant

Provider of therapeutics solutions for treating autoimmune diseases

placeNew York City, New York, United States calendar_todayFounded 2016 groups1 employees language immunovant.com

Registered entities

Social engagement

Social engagement: 21.4K social following, 8 posts in the last 12 months — around the industry typical range.

Investor mix

6 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital233%
Private equity350%
Other / undisclosed117%

Recent activity

11 Jun 2026
Event
ENDO 2026
Coming soon